The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Slyndy 4 mg film-coated tablets

Exeltis healthcare S.L.PA22998/002/001

Main Information

Trade NameSlyndy 4 mg film-coated tablets
Active SubstancesDrospirenone
Dosage FormFilm-coated tablet
Licence HolderExeltis healthcare S.L.
Licence NumberPA22998/002/001

Group Information

ATC CodeQG03AC10 drospirenone


License statusAuthorised
Licence Issued23/07/2021
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back